{"id":"W3197361064","doi":"10.1111/bjh.17807","title":"<i>BCR–ABL1</i> transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase","year":2021,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Toronto General Hospital; University of Alberta; London Health Sciences Centre; Hôpital de l'Enfant-Jésus; Queen Elizabeth II Health Sciences Centre; Dalhousie University; Université de Montréal; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Vancouver General Hospital; University of Calgary; BC Cancer Agency; Alberta Health Services; McGill University Health Centre; University of Ottawa; Calgary Laboratory Services; CancerCare Manitoba; Ottawa Hospital; University Health Network; Western University; University of Toronto; University of British Columbia","funders":"Bristol-Myers Squibb Canada; Princess Margaret Cancer Foundation; Novartis","keywords":"Discontinuation; Imatinib; Chronic myeloid leukaemia; Internal medicine; Medicine; Doubling time; Imatinib mesylate; Gastroenterology; breakpoint cluster region; Oncology; Immunology; Myeloid leukemia; Biology; Cell; Genetics; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007351709,0.0001886988,0.0003513584,0.0004087033,0.0002168153,0.0003994919,0.0001963859,0.0003803725,0.0004697268],"category_scores_gemma":[0.001834908,0.0001369048,0.000304442,0.0004064405,0.000225906,0.0001924399,0.0002527857,0.0004702093,0.0001421833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003014808,"about_ca_system_score_gemma":0.0002102562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001173353,"about_ca_topic_score_gemma":0.001320158,"domain_scores_codex":[0.9996654,0.00009457908,0.00004279094,0.00006737425,0.00006775972,0.00006213713],"domain_scores_gemma":[0.9977029,0.0006870323,0.001197818,0.00007419658,0.00008342512,0.0002547155],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001410455,0.0000336633,0.989029,0.00001781472,0.00004185113,0.0001116943,0.00006248229,0.0002436927,0.002596264,0.00001573836,0.00008361063,0.006353695],"study_design_scores_gemma":[0.00001818097,0.0003450373,0.9979284,0.000004365019,0.0000358886,0.0004542483,0.00003284396,0.0005581114,0.0003918388,0.00001993444,0.0002057338,0.000005559582],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993196,0.0003990254,0.00008643251,0.00001443931,0.000002815409,0.00000306282,0.00006241188,0.000002846367,0.0001094322],"genre_scores_gemma":[0.9997103,0.00004716782,0.00005546524,0.000007808336,0.000005687228,0.000003334026,0.0001188376,0.000001407505,0.00004991745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001173353,"threshold_uncertainty_score":0.003887951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01379280525147776,"score_gpt":0.2961651463502976,"score_spread":0.2823723410988199,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}